After so many years fatty liver disease was not receiving enough attention, it seems that all major health institutes are changing their view on this disease. One of the major of such groups, The Liver Meeting® (AASLD), which a a global health organization about liver diseases, held its annual meetings in 2014, and they decided to switch […]
About Dr. Mark Bar-Gomel
This author has yet to write their bio.Meanwhile lets just say that we are proud Dr. Mark Bar-Gomel contributed a whooping 49 entries.
Entries by Dr. Mark Bar-Gomel
Most people never hear of fatty liver until they (or someone close to him) have been diagnosed with it. Most of us who were diagnosed with fatty liver don’t know what to expect and their doctor doesn’t tell them everything they need to know. So I asked many of my patients a simple question. When you learned […]
The Indian drug company Zydus Cadila is in the process to develop a real medicine for fatty liver disease. As many of you might know, at this moment there are no actual medicine treatment for fatty liver, so this might be the first drug for the disease. The drug itself is based on another drug that […]
A new data mentioned in the International Liver Congress 2015 shows that statistically, cardiovascular diseases are common in people with nonalcoholic fatty liver. That includes kidney diseases, stroke & heart failure. This information has been collected from a 14-year analysis of data collected of 929,465 patients from 2000 to 2013 from several hospitals in England. […]
The Liver Meeting® (AASLD) 2014 has now switched the main focus on liver diseases on Fatty Liver. The main reason is that a cure for Hepatitis C is now a reality, thus making fatty liver as the most emerging cause of chronic liver diseases. I’ve been saying for more than a decade that Fatty Liver is […]